Taken together, these findings suggest that linifanib induces HCC cells autophagy in vivo through inhibiting the phosphorylation of PDGFR-β and its down-stream Akt/mTOR and Mek/Erk signaling pathways. Here, AKT1 is linked to hepatocellular carcinoma.